[go: up one dir, main page]

DE602004011921D1 - Verfahren zur herstellung von (4-hydroxy-6-oxo-tetrahydropyran-2-yl) acetonitril und dessen derivaten - Google Patents

Verfahren zur herstellung von (4-hydroxy-6-oxo-tetrahydropyran-2-yl) acetonitril und dessen derivaten

Info

Publication number
DE602004011921D1
DE602004011921D1 DE602004011921T DE602004011921T DE602004011921D1 DE 602004011921 D1 DE602004011921 D1 DE 602004011921D1 DE 602004011921 T DE602004011921 T DE 602004011921T DE 602004011921 T DE602004011921 T DE 602004011921T DE 602004011921 D1 DE602004011921 D1 DE 602004011921D1
Authority
DE
Germany
Prior art keywords
hydroxy
oxo
acetonitrile
pyran
tetrahydro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602004011921T
Other languages
English (en)
Other versions
DE602004011921T2 (de
Inventor
Daniel Mink
Michael Wolberg
Wilhelmus Hubertus Boesten
Natascha Sereinig
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centrient Pharmaceuticals Netherlands BV
Original Assignee
DSM IP Assets BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DSM IP Assets BV filed Critical DSM IP Assets BV
Publication of DE602004011921D1 publication Critical patent/DE602004011921D1/de
Application granted granted Critical
Publication of DE602004011921T2 publication Critical patent/DE602004011921T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30Oxygen atoms, e.g. delta-lactones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Epoxy Compounds (AREA)
DE602004011921T 2003-05-02 2004-04-28 Verfahren zur herstellung von (4-hydroxy-6-oxo-tetrahydropyran-2-yl) acetonitril und dessen derivaten Expired - Lifetime DE602004011921T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP03101227 2003-05-02
EP03101227 2003-05-02
PCT/NL2004/000284 WO2004096788A1 (en) 2003-05-02 2004-04-28 Process fot the preparation of (4-hydroxy-6-oxo-tetrahydropyran-2-yl) acetonitrile and derivatives thereof

Publications (2)

Publication Number Publication Date
DE602004011921D1 true DE602004011921D1 (de) 2008-04-03
DE602004011921T2 DE602004011921T2 (de) 2009-02-19

Family

ID=33395971

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004011921T Expired - Lifetime DE602004011921T2 (de) 2003-05-02 2004-04-28 Verfahren zur herstellung von (4-hydroxy-6-oxo-tetrahydropyran-2-yl) acetonitril und dessen derivaten

Country Status (24)

Country Link
US (1) US7423162B2 (de)
EP (1) EP1620423B1 (de)
JP (1) JP2006525323A (de)
KR (1) KR20060011984A (de)
CN (2) CN1780826B (de)
AT (1) ATE386734T1 (de)
AU (1) AU2004234308A1 (de)
BR (1) BRPI0409866A (de)
CA (1) CA2524457A1 (de)
CO (1) CO5700715A2 (de)
CY (1) CY1113498T1 (de)
DE (1) DE602004011921T2 (de)
DK (1) DK1620423T3 (de)
EA (1) EA010100B1 (de)
ES (1) ES2300769T3 (de)
IL (1) IL171539A (de)
IS (1) IS8159A (de)
NO (1) NO20055694L (de)
NZ (1) NZ543294A (de)
PL (1) PL1620423T3 (de)
SI (1) SI1620423T1 (de)
UA (1) UA83662C2 (de)
WO (1) WO2004096788A1 (de)
ZA (1) ZA200508862B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20051020A2 (hr) * 2003-07-25 2006-04-30 Avecia Pharmaceuticals Limited Postupak i međuspojevi korisni u dobivanju statina, posebice atorvastatin
US7701550B2 (en) 2004-08-19 2010-04-20 Asml Netherlands B.V. Lithographic apparatus and device manufacturing method
DE102005022284A1 (de) * 2005-05-13 2006-11-23 Ratiopharm Gmbh Verfahren zur Herstellung von Statinen
US8047545B2 (en) * 2007-11-07 2011-11-01 Douglas Press, Inc. Lottery-type game with rollover feature
US8404870B2 (en) * 2008-01-23 2013-03-26 Lek Pharmaceuticals D.D. ((2S,4R)-4,6-dihydroxytetrahydro-2H-pyran-2-yl)methyl carboxylate and process for the production thereof
WO2012032035A1 (en) 2010-09-09 2012-03-15 Dsm Sinochem Pharmaceuticals Netherlands B.V. Salts of 7-amino-3,5-dihydroxyheptanoic acid esters
MX2013002809A (es) * 2010-09-16 2013-04-29 Dsm Sinochem Pharm Nl Bv Esteres de acidos hexanoicos.
CN105669637A (zh) * 2014-11-21 2016-06-15 南京博优康远生物医药科技有限公司 一种3,5,6-取代己酸酯衍生物的制备方法
CN112501223B (zh) * 2020-11-23 2022-08-12 江苏阿尔法药业股份有限公司 制备2-((2r,4r)-4-羟基-6-氧代四氢-2h-吡喃-2-基)乙腈的方法
CN116102482A (zh) * 2022-08-17 2023-05-12 重庆普佑生物医药有限公司 一种阿托伐他汀钙的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5003080A (en) 1988-02-22 1991-03-26 Warner-Lambert Company Process for trans-6-(2-(substituted-pyrrol-1-yl)alkyl)pryan-2-one inhibitors of cholesterol synthesis
US5097045A (en) * 1989-02-01 1992-03-17 Warner-Lambert Company Process for trans-6-[2-(substituted-pyrrol-1-yl)alkyl]pyran-2-one inhibitors of cholesterol synthesis
NL1015744C2 (nl) * 2000-07-19 2002-01-22 Dsm Nv Werkwijze voor de bereiding van 2-(6-gesubstitueerde-1,3-dioxan-4-yl) azijnzuurderivaten.
AU2003263031A1 (en) * 2002-09-20 2004-04-08 Diversa Corporation Chemoenzymatic methods for the synthesis of statins and stain intermediates

Also Published As

Publication number Publication date
IS8159A (is) 2005-11-30
EP1620423B1 (de) 2008-02-20
CY1113498T1 (el) 2016-06-22
ATE386734T1 (de) 2008-03-15
JP2006525323A (ja) 2006-11-09
US20060258733A1 (en) 2006-11-16
EP1620423A1 (de) 2006-02-01
CN101775000A (zh) 2010-07-14
NO20055694L (no) 2006-02-02
NO20055694D0 (no) 2005-12-01
EA010100B1 (ru) 2008-06-30
CO5700715A2 (es) 2006-11-30
BRPI0409866A (pt) 2006-05-16
AU2004234308A1 (en) 2004-11-11
KR20060011984A (ko) 2006-02-06
DE602004011921T2 (de) 2009-02-19
EA200501734A1 (ru) 2006-04-28
CN101775000B (zh) 2014-09-24
IL171539A (en) 2011-03-31
CN1780826B (zh) 2010-05-26
DK1620423T3 (da) 2008-05-26
ES2300769T3 (es) 2008-06-16
CN1780826A (zh) 2006-05-31
SI1620423T1 (sl) 2008-06-30
US7423162B2 (en) 2008-09-09
NZ543294A (en) 2008-05-30
CA2524457A1 (en) 2004-11-11
UA83662C2 (ru) 2008-08-11
WO2004096788A1 (en) 2004-11-11
ZA200508862B (en) 2007-02-28
PL1620423T3 (pl) 2008-07-31

Similar Documents

Publication Publication Date Title
TW200519106A (en) Organic compounds
ATE481987T1 (de) Verfahren zur radiofluoridierung von biologisch aktiven vektoren
MX2008014101A (es) Acidos carboxilicos sustituidos con 4,5-difenil-pirimidinilamino, metodo para su produccion y su uso como medicamentos.
MY135050A (en) Organic compounds
DE602004030239D1 (de) Verfahren und zwischenprodukte zur herstellung von (1r,2s,5s)-6,6-dimethyl-3-azabicycloä3,1,0 ühexan-2-carboxylaten oder salzen davon
PL377838A1 (pl) Zastosowanie pochodnych N-(1-benzylo-2-okso-2-(piperazynylo)etylo)-1-piperydynokarboksyamidowych oraz pokrewnych związków jako antagonistów CGRP do leczenia bólu głowy
MY142029A (en) Phenoxyacetic acid derivatives
MY148483A (en) 4,5-diphenyl-pyrimidinyl-oxy or-mercapto substituted carboxylic acids, method for the production and use thereof as medicaments
GB0305152D0 (en) Organic compounds
CA2417652A1 (en) Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them
MX2010003849A (es) Antagonistas de cgrp.
CY1113498T1 (el) Διαδικασια για την παρασκευη (4-υδροξυ-6-οξο-τετραϋδροπυραν-2-υλ) ακετονιτριλιου και παραγωγων αυτου
EA200800502A1 (ru) Соединения 3-аминокарбазола, фармацевтическая композиция, содержащая указанные соединения, и способ их получения
IL157046A0 (en) Phthalic acid diamide, method for the production thereof and the use of the same as a pesticide
DE502004009152D1 (de) Verfahren zur herstellung von derivaten des 4a,5,9,10,11,12-hexahydrobenzofuro ä3a,3,2üä 2 ü- benzazepins
DE602004025935D1 (de) Histondeacetylaseinhibitor und verfahren zu dessen herstellung
EP1944027A4 (de) Pharmazeutische zusammensetzung zur behandlung oder prävention von nephritis und herstellungsverfahren dafür
YU81502A (sh) Ciklopostini, postupak za njihovu proizvodnju i njihova primena
DE502005009501D1 (de) Verfahren zur herstellung von candesartan
DE502004006253D1 (de) Substituierte benzoylureidopyridyl-piperidin- und -pyrrolidin-carbons urederivate, verfahren zu deren herstellung und deren v erwendung
TNSN06233A1 (en) 7-phenylamino-4-quinolone-3-carboxylic acid derivatives, methods for production and use thereof as medicaments
ATE451367T1 (de) Verfahren zur herstellung von ziprasidon
DE60327567D1 (de) Verfahren zur herstellung von 3,3',4,4'-tetraaminobiphenyl
DE60225338D1 (de) Verfahren zur herstellung von derivaten von 3,3-dimethyl-2-formylcyclopropanekarbonsäure
DE602005018770D1 (de) Verfahren zur herstellung von 1,5-diphenylpyrazolcarbonsäurederivaten

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
R081 Change of applicant/patentee

Ref document number: 1620423

Country of ref document: EP

Owner name: DSM SINOCHEM PHARMACEUTICALS NETHERLANDS B.V., NL

Free format text: FORMER OWNER: DSM IP ASSETS B.V., HEERLEN, NL

Effective date: 20120731

R082 Change of representative

Ref document number: 1620423

Country of ref document: EP

Representative=s name: ,

Effective date: 20120822